RRPV Solicitation Summary: NextGen Oral Formulation Vaccines for COVID-19
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
|---|---|
| State: | District of Columbia |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Posted Date: | Oct 1, 2024 |
| Due Date: | Nov 1, 2024 |
| Solicitation No: | RRPV-24-02-OralVx |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
- Contract Opportunity Type: Special Notice (Updated)
- Updated Published Date: Oct 01, 2024 03:02 pm EDT
- Original Published Date: Sep 10, 2024 07:04 am EDT
- Updated Response Date: Nov 01, 2024 01:00 pm EDT
- Original Response Date: Oct 18, 2024 01:00 pm EDT
- Inactive Policy: 15 days after response date
- Updated Inactive Date: Nov 16, 2024
- Original Inactive Date: Nov 02, 2024
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: AN42 - HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH
-
NAICS Code:
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
-
Place of Performance:
DCUSA
This solicitation summary is to notify all potential offerors of a Request for Project Proposals (RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of the Biomedical Advanced Research and Development Authority (BARDA) titled, "NextGen Oral Formulation Vaccines for COVID-19". The purpose of this effort is to advance oral vaccine platforms and technologies into a proof-of-concept Phase 1 clinical trial, improve our understanding of their potential, and to provide better COVID-19 solutions and bolster preparedness and response against future health security threats. The full RPP and information on joining the consortium can be accessed through the RRPV website at www.rrpv.org.
Amended to extend the due date from 18 October 2024 to 1 November 2024.
- O’NEILL HOUSE OFFICE BUILDING
- WASHINGTON , DC 20515
- USA
- Rebecca Harmon
- rebecca.harmon@ati.org
Related Document
| Sep 10, 2024 | [Special Notice (Original)] RRPV Solicitation Summary: NextGen Oral Formulation Vaccines for COVID-19 |
| Oct 29, 2024 | [Special Notice (Updated)] RRPV Solicitation Summary: NextGen Oral Formulation Vaccines for COVID-19 |
See Also
Solicitation # Details Opening Date Closing Date Other Documents DCSC-26-RFPQ-1 Establishing a Roster
District of Columbia Courts
Due by 9/30/2026
Follow Research Initiatives in Support of FHWA Next Generation Structural Materials and Systems
TRANSPORTATION, DEPARTMENT OF
Due by 4/01/2029
Follow Federal Bureau of Investigation (FBI) - Office of Chief Information Officer (OCIO)
JUSTICE, DEPARTMENT OF
Due by 5/16/2027
Follow FTA Broad Agency Announcement (FY26) -- "Research Initiatives in Support of Safety,
TRANSPORTATION, DEPARTMENT OF
Due by 10/19/2026